Showing 4 of 64 recruiting trials for “angiocentric-glioma”
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
👨⚕️ Andrew J Brenner, PhD, The Cancer Therapy and Research Center at UTHSCSA📍 3 sites📅 Started Jun 2015View details ↗
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
RecruitingNCT01772771 ↗
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
👨⚕️ Robert Young, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started Mar 2009View details ↗
← PreviousPage 4 of 4
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →